Rift Valley fever virus: an unrecognized emerging threat?

scientific article published on July 2010

Rift Valley fever virus: an unrecognized emerging threat? is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.4161/HV.6.7.11761
P8608Fatcat IDrelease_crdsu2zdwzgd7ddj2tkcbkyrbq
P698PubMed publication ID20421731
P5875ResearchGate publication ID43345930

P2093author name stringRamon Flick
Robert B Mandell
P433issue7
P921main subjectRift Valley fever phlebovirusQ24809101
Rift Valley feverQ326638
Rift Valley fever virusQ14276794
P304page(s)597-601
P577publication date2010-07-01
P1433published inHum VaccinQ15755183
P1476titleRift Valley fever virus: an unrecognized emerging threat?
P478volume6

Reverse relations

cites work (P2860)
Q47547438Anti-Rift Valley fever virus activity in vitro, pre-clinical pharmacokinetics and oral bioavailability of benzavir-2, a broad-acting antiviral compound.
Q30152032Biochemical and biophysical characterization of cell-free synthesized Rift Valley fever virus nucleoprotein capsids enables in vitro screening to identify novel antivirals
Q33705717Countermeasure development for Rift Valley fever: deletion, modification or targeting of major virulence factor NSs
Q34429914Functional analysis of Rift Valley fever virus NSs encoding a partial truncation
Q36414512Genetic subpopulations of Rift Valley fever virus strains ZH548 and MP-12 and recombinant MP-12 strains
Q96304864Livestock Challenge Models of Rift Valley Fever for Agricultural Vaccine Testing
Q43167772Overlapping CD8+ and CD4+ T-cell epitopes identification for the progression of epitope-based peptide vaccine from nucleocapsid and glycoprotein of emerging Rift Valley fever virus using immunoinformatics approach.
Q34165833Predicting the mosquito species and vertebrate species involved in the theoretical transmission of Rift Valley fever virus in the United States
Q36514844Rift Valley fever MP-12 vaccine Phase 2 clinical trial: Safety, immunogenicity, and genetic characterization of virus isolates.
Q36501737Rift Valley fever virus NSs inhibits host transcription independently of the degradation of dsRNA-dependent protein kinase PKR.
Q47549408Seroprevalence of Rift Valley Fever Virus Antibodies in Cattle in Mali, 2005-2014.
Q37433779Short Interfering RNA Inhibits Rift Valley Fever Virus Replication and Degradation of Protein Kinase R in Human Cells
Q36155392The dominant-negative inhibition of double-stranded RNA-dependent protein kinase PKR increases the efficacy of Rift Valley fever virus MP-12 vaccine
Q37433782The risk of Rift Valley fever virus introduction and establishment in the United States and European Union
Q40254473Virus-like particle-based countermeasures against Rift Valley fever virus

Search more.